To include your compound in the COVID-19 Resource Center, submit it here.

Seeing double

Carl Icahn doubles his money on Biogen Idec, reduces stake by half

Seeing double

Carl Icahn has sold almost half of his stake in Biogen Idec Inc. (NASDAQ:BIIB) over the last few months for about twice what he paid for

Read the full 271 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers